M&A Deal Summary |
|
|---|---|
| Date | 2021-01-11 |
| Target | Max-Inf |
| Sector | Consumer Products |
| Buyer(s) | Trustar Capital |
| Sellers(s) | Nordic Capital |
| Deal Type | Secondary Buyout |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1978 |
| PE ASSETS | 7.7B USD |
| Size | Mega |
| Type | Sector Agnostic |
Trustar Capital is the private equity arm of financial services/asset manager CITIC Group. Trustar Capital separates its private equity investment activity into three groups; China, Japan, and the US. In general, Trustar looks to invest in companies with 'strong franchises', with established brands and high barriers to entry. For US-based opportunities, the firm looks to leverage its connections in China. Broad areas of interest include niche manufacturing, consumer products, and business services. The Firm does not invest in start-ups or distressed businesses. Trustar Capital is based in Hong Kong.
| DEAL STATS | # |
|---|---|
| Overall | 44 of 52 |
| Sector (Consumer Products) | 4 of 5 |
| Type (Secondary Buyout) | 11 of 11 |
| Country (China) | 17 of 22 |
| Year (2021) | 1 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-11-16 |
ISI Markets
London, United Kingdom ISI Markets is a provider of data, analysis, and research for the world's fastest-growing and highest potential countries. It aggregates unstructured, hard-to-obtain information from local and international sources, and validates and curates it into standardized, methodologically consistent, and editable content. The products are trusted tools used by a large and diversified customer base made up of blue-chip financial institutions, multinationals, consultants, and researchers worldwide and are available in over 15 languages. ISI operates a subscription model, providing customers with business-critical emerging markets research, leveraging real-time macroeconomic, business, and industry intelligence across multiple use cases. ISI Markets was formed in 1992 and is based in London, United Kingdom. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-01-22 |
ReClassified
Shanghai, China ReClassified is a scented personal care products brand which includes perfume, home fragrance, car fragrance and scented candles. ReClassified was founded in 2013 and is based in Shanghai, China. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1989 |
| PE ASSETS | 31.0B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Nordic Capital is a private equity investment firm that targets mid to large-sized company investments located in Northern Europe as well as the US. Nordic seeks investments across a wide range of industries and prefers situations where there are 'opportunities for new industrial combinations, strategic repositioning, international expansion and operational improvements'. Nordic Capital was formed in 1989 and is based in Stockholm, Sweden.
| DEAL STATS | # |
|---|---|
| Overall | 64 of 79 |
| Sector (Consumer Products) | 5 of 5 |
| Type (Secondary Buyout) | 16 of 22 |
| Country (China) | 1 of 1 |
| Year (2021) | 1 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-12-21 |
Cytel
Cambridge, Massachusetts, United States Cytel is a provider of analytical software and services for the life sciences sector. Cytel helps leading pharmaceutical, biotech, and medical device companies improve clinical success rates via optimal study design, effective data management, and accurate statistical analysis. Cytel was founded in 1987 and is based in Cambridge, Massachusetts. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-01-27 |
ADVANZ PHARMA
London, United Kingdom ADVANZ PHARMA is a specialty pharmaceutical company with a strategic focus on complex medicines with direct sales access in Europe and a global distribution network. ADVANZ PHARMA was founded in 1963 and is based in London, United Kingdom. |
Buy | $846M |
